SEC-sourced researchBeta
CPHI
CHINA PHARMA HOLDINGS, INC.
Company comparison ↗
Data passport
- CIK
- 0001106644
- Exchange
- NYSE
- Business activity
- — · SIC 2834
- Financial inputs
- 6/6
- Filing date
- Apr 1, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 4,528,929.0000 | Apr 1, 2026 |
| December 2025 | 4,144,268.0000 | Apr 1, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 4,144,268.0000 | -3,187,556.0000 | 148,261.0000 | 30,999,464.0000 | 8,259,712.0000 | Apr 1, 2026 |
| December 2024 | 4,528,929.0000 | -4,736,365.0000 | -406,063.0000 | 14,887,524.0000 | 7,139,620.0000 | Apr 1, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $4.14M | December 2025 | Apr 1, 2026 | 10-K |
| Previous period revenueRevenues | $4.53M | December 2024 | Apr 1, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$3.19M | December 2025 | Apr 1, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $148.26K | December 2025 | Apr 1, 2026 | 10-K |
| Total assetsAssets | $31M | December 2025 | Apr 1, 2026 | 10-K |
| Total liabilitiesLiabilities | $8.26M | December 2025 | Apr 1, 2026 | 10-K |